Literature DB >> 9179787

Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat.

F C Krebs1, M M Goodenow, B Wigdahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179787

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  17 in total

1.  Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway.

Authors:  Valya Ramakrishnan; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2011-04-15       Impact factor: 3.039

2.  Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Authors:  Yujie Liu; Michael R Nonnemacher; Devin L Stauff; Luna Li; Anupam Banerjee; Bryan Irish; Evelyn Kilareski; Nirmala Rajagopalan; Joyce B Suchitra; Zafar K Khan; Udaykumar Ranga; Brian Wigdahl
Journal:  Biomed Pharmacother       Date:  2010-09-25       Impact factor: 6.529

Review 3.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

4.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 5.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

6.  Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

Authors:  Jose Sangerman; Moo Seung Lee; Xiao Yao; Eugene Oteng; Cheng-Hui Hsiao; Wei Li; Sima Zein; Solomon F Ofori-Acquah; Betty S Pace
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

7.  Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.

Authors:  Tricia H Hogan; Devin L Stauff; Fred C Krebs; Suzanne Gartner; Shane J Quiterio; Brian Wigdahl
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

8.  Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.

Authors:  H L Ross; M R Nonnemacher; T H Hogan; S J Quiterio; A Henderson; J J McAllister; F C Krebs; B Wigdahl
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.

Authors:  Keith William Jarosinski; Priscilla Helene O'Connell; Karel Antoni Schat
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.